SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,108,126 | +76698.8% | 719,497 | +48.1% | 0.00% | 0.0% |
Q1 2024 | $2,745 | -2.4% | 485,797 | -25.9% | 0.00% | 0.0% |
Q4 2023 | $2,813 | +167.6% | 655,797 | +116.5% | 0.00% | +100.0% |
Q3 2023 | $1,051 | -16.1% | 302,897 | +12.4% | 0.00% | 0.0% |
Q2 2023 | $1,253 | +109.5% | 269,497 | +108.3% | 0.00% | +100.0% |
Q1 2023 | $598 | +147.1% | 129,397 | +332.8% | 0.00% | – |
Q4 2022 | $242 | -100.0% | 29,900 | -86.2% | 0.00% | -100.0% |
Q3 2022 | $1,198,000 | +55.6% | 215,900 | +46.2% | 0.00% | +100.0% |
Q2 2022 | $770,000 | +6.2% | 147,700 | +203.3% | 0.00% | 0.0% |
Q4 2021 | $725,000 | +11.2% | 48,700 | +62.3% | 0.00% | 0.0% |
Q4 2020 | $652,000 | -43.8% | 30,014 | -79.9% | 0.00% | 0.0% |
Q2 2020 | $1,160,000 | +926.5% | 149,513 | +1351.6% | 0.00% | – |
Q4 2019 | $113,000 | – | 10,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |